Search Results 1241-1250 of 74607 for Molecular
Mayo Clinic investigator Samuel O. Antwi, Ph.D., studies genetic, molecular and nongenetic risk factors for hepatocellular carcinoma and pancreatic cancer.
Advanced cellular, molecular and immunologic techniques. Single-cell, spatial and metabolic profiling approaches. Data analysis, interpretation and ...
— Mayo Clinic Laboratories, a global leader in advanced laboratory testing, and Lucence, a pioneering molecular diagnostics company, announced a strategic ...
... molecular risk stratification in the treatment of rhabdomyosarcoma. Additionally, to find out how well patients with low risk rhabdomyosarcoma (LR-RMS) ...
Hancheng Cai, PhD, is a radiochemist and molecular imaging scientist. My clinical work focus on FDA cGMP PET drug production facility implementation and ...
Mayo Clinic's Gastrointestinal Mechanotransduction Lab led by Arthur Beyder, M.D., Ph.D., studies motility at the molecular level to discover new treatments ...
Innovative breast imaging techniques, such as dynamic contrast-enhanced MRI, contrast-enhanced digital mammography and molecular breast imaging. Making ...
The Cellular and Molecular Physiology of Gastrointestinal Disorders Lab, led by Gianrico Farrugia, M.D., studies the regulation of gastrointestinal motility in ...
"This molecule is a protease, which means it digests other molecules. Our data suggests PRSS3 activity changes the environment around prostate cancer cells — ...
D. Professor of Biochemistry and Molecular Biology & Orthopedics. Jennifer J. Westendorf, Ph.D., is a consultant in the Department ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.